The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.
Actavis plc has opened its new regional office in Singapore that will serve as the headquarters for the company's Asia Pacific and Africa (APACA) region. In addition, Actavis announced that its subsidiary operating in Singapore—Drug...
Teva Pharmaceutical Industries Ltd. announces the approval of the generic equivalent to Lovaza® (omega-3-acid ethyl esters aapsules, USP), in the United States. "Teva believes it is first-to-file and thus far is the only company to receive an...
Novartis appointed Jeff George as division head of Alcon, effective May 1, 2014. He succeeds Kevin Buehler who is retiring from the company after a 30-year career at Alcon. As part of the planned transition, Buehler will...
Kyowa Hakko Kirin Co., Ltd. has completed the construction of an biopharmaceutical API manufacturing facility at its Takasaki site in Japan. The company invested 6 billion yen ($58.8 million) for the facility, which includes a 12,000-L...
Takeda Pharmaceuticals and Eli Lilly issued the following statement today in response to the verdict in the case of Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc., et al. No. 6:12-cv-00064 regarding claims that Takeda's...
Mersana Therapeutics, a company specializing antibody drug conjugates (ADCs) and related technology, has entered into a collaboration agreement with Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company...
Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd have entered into definitive agreements under which Sun Pharma will acquire 100% of Ranbaxy in an all-stock transaction for $3.2 billion. Under these agreements, Ranbaxy...
Sanofi and its subsidiary Genzyme report that following discussions with FDA, the company plans to resubmit in the second quarter its supplemental biologics license application seeking approval of Lemtrada (alemtuzumab) for the treatment...
The specialty pharmaceutical company Mallinckrodt plc and the biopharmaceutical Questcor Pharmaceuticals have entered into a definitive merger agreement under which Mallinckrodt will acquire Questcor in a transaction valued at approximately $5.6...
Alexion Pharma International Trading, a subsidiary of the biopharmaceutical company Alexion Pharmaceuticals Inc., plans to expand its operations in Ireland following the acquisition of a new site in West Dublin, according to a press statement...
FDA has issued an import alert to the generic-drug maker Apotex for products manufactured at the company's Bangalore, India facility. The import ban applies to all drugs and antibiotics, with the exception of riluzole, which is a drug used to slow...
Impax Laboratories Inc. has appointed Jeffrey D. Nornhold as senior vice-president, technical operations and will oversee the company's manufacturing, supply chain, quality and technical operations. Nornhold previously served as the company's...
Baxter International Inc. has agreed to acquire all of the outstanding membership interests of Chatham Therapeutics for $70 million. As a result of the transaction, Baxter will acquire Chatham's developmental gene therapy programs directed toward...
The specialty pharmaceutical company Pernix Therapeutics Holdings, Inc. has agreed to divest its Houston, Texas-based manufacturing operations, Pernix Manufacturing, LLC (PML) to Woodfield Pharmaceutical LLC . Woodfield will acquire the entire PML...
Par Pharmaceutical Companies, Inc. has named Terrance J. Coughlin chief operating officer. In this capacity, Coughlin will be responsible for Par's global manufacturing activities, research and development efforts and will be instrumental in...
